Theratechnologies Inc T.TH

CQDM

[scarlet1967]

THTX and CQDM are working on research projects related to metastasis cancers. 

https://www.theratech.com/news-releases/news-release-details/cqdm-quebec-breast-cancer-foundation-and-theratechnologies-fund/

 

"The SAB is a key committee of CQDM as it provides strategic orientations in biopharmaceutical innovation and oversees the selection and monitoring of projects funded by CQDM.

Kuldeep Neote is an Entrepreneur-in-Residence at the National Institutes of Health and at FACIT/OICR, an investment firm focused on accelerating the commercialization of oncology innovations and located in Toronto. Kuldeep is a molecular biologist by training and has many years of experience in drug discovery in the areas of immunology, inflammation and oncology. Among other things, he has established a drug discovery platform for chemokine receptors, which has led to the discovery and development of several clinical candidates. In recent years, Kuldeep has worked as an advisor to identify scientifically innovative and commercially viable candidates for partnership or investment. His rich and impressive track record in various pharmaceutical companies and his long-standing interest in integrating cutting-edge scientific discoveries into drug discovery programs, gives him a unique expertise that will be a major asset to the SAB and CQDM."

 

CQDM nominates Kuldeep Neote

 

 

 

[Trogarzon]

Maybe this guy finds a way to make Th1902 work the way it should on humans... Go Kuldeep go.... and take us out od the deep s  t  where in. lol

[Trogarzon]

In the end there is enough quality people and science in THTX to make something out of it eventually.  That's what keeps me invested.

[Wino115]

I know this is "research", but there is some significance to this (in the mid term, not immediately) because it's furthering the work they did 12-18 months ago showing that if you just do a pre and a post-therapy administration of TH1902, you see a very large effect at stopping metastices.  I believe the original study was of breast cancer cells and their typical metastices to

[PWIB123]

This press release is from July 2022.  Are there any additional updates, now that this is 8 months old?  I'm also not so sure that THTX didn't participate in the funding of the research based on the headline.  It says ...and THTX fund close to $2MM.   

[realitycheck4u]

This post has been removed in accordance with Community Policy

[scarlet1967]

One thing which in my opinion is significant even these are preclinical studies is "weekly" intervals and dosage equal to docetaxel's MTD, so they seems to have aligned the dosing with what they are saying about the frequency and dosage for the restart . We don't know when the recent preclinical studies were initiated and concluded but in the past CPs changing dosing intervals